These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36183964)

  • 21. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
    Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
    J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pon1 Deficiency Promotes Trem2 Pathway-Mediated Microglial Phagocytosis and Inhibits Pro-inflammatory Cytokines Release In Vitro and In Vivo.
    Zhang L; Dong W; Ma Y; Bai L; Zhang X; Sun C; Li J; Zhang L
    Mol Neurobiol; 2022 Jul; 59(7):4612-4629. PubMed ID: 35589918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maprotiline ameliorates isoflurane-induced microglial activation via regulating triggering receptor expressed in myeloid cells 2 (TREM2).
    Hu R; He Y; Chen Z
    Bioengineered; 2021 Dec; 12(2):12332-12344. PubMed ID: 34895041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration.
    Bhattacharjee S; Zhao Y; Dua P; Rogaev EI; Lukiw WJ
    PLoS One; 2016; 11(3):e0150211. PubMed ID: 26949937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
    Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
    MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TREM2 regulates microglial cell activation in response to demyelination in vivo.
    Cantoni C; Bollman B; Licastro D; Xie M; Mikesell R; Schmidt R; Yuede CM; Galimberti D; Olivecrona G; Klein RS; Cross AH; Otero K; Piccio L
    Acta Neuropathol; 2015 Mar; 129(3):429-47. PubMed ID: 25631124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.
    Qu W; Li L
    J Neurosci; 2020 Dec; 40(50):9552-9563. PubMed ID: 33139402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.
    Reich M; Paris I; Ebeling M; Dahm N; Schweitzer C; Reinhardt D; Schmucki R; Prasad M; Köchl F; Leist M; Cowley SA; Zhang JD; Patsch C; Gutbier S; Britschgi M
    Front Immunol; 2020; 11():617860. PubMed ID: 33613545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depletion and activation of microglia impact metabolic connectivity of the mouse brain.
    Gnörich J; Reifschneider A; Wind K; Zatcepin A; Kunte ST; Beumers P; Bartos LM; Wiedemann T; Grosch M; Xiang X; Fard MK; Ruch F; Werner G; Koehler M; Slemann L; Hummel S; Briel N; Blume T; Shi Y; Biechele G; Beyer L; Eckenweber F; Scheifele M; Bartenstein P; Albert NL; Herms J; Tahirovic S; Haass C; Capell A; Ziegler S; Brendel M
    J Neuroinflammation; 2023 Feb; 20(1):47. PubMed ID: 36829182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TREM2 deficiency in microglia accelerates photoreceptor cell death and immune cell infiltration following retinal detachment.
    Zhou W; Zhou Y; He J; Rao Y; Fei P; Li J
    Cell Death Dis; 2023 Mar; 14(3):219. PubMed ID: 36977680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma.
    Sun R; Han R; McCornack C; Khan S; Tabor GT; Chen Y; Hou J; Jiang H; Schoch KM; Mao DD; Cleary R; Yang A; Liu Q; Luo J; Petti A; Miller TM; Ulrich JD; Holtzman DM; Kim AH
    Sci Adv; 2023 May; 9(19):eade3559. PubMed ID: 37172094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
    Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
    Varnum MM; Clayton KA; Yoshii-Kitahara A; Yonemoto G; Koro L; Ikezu S; Ikezu T
    J Biol Chem; 2017 Jun; 292(25):10651-10663. PubMed ID: 28490631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Active Ingredients Targeted TREM2 by SPR Biosensor-UPLC/MS Recognition System, and Investigating the Mechanism of Anti-Neuroinflammatory Activity on the Lignin-Amides from
    Wang SY; Liu Y; Li XM; Algradi AM; Jiang H; Sun YP; Guan W; Pan J; Kuang HX; Yang BY
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
    Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
    Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the Aβ
    Qin Z; Gu M; Zhou J; Zhang W; Zhao N; Lü Y; Yu W
    Synapse; 2020 Oct; 74(10):e22161. PubMed ID: 32412103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.
    Cheng B; Li X; Dai K; Duan S; Rong Z; Chen Y; Lü L; Liu Z; Huang X; Xu H; Zhang YW; Zheng H
    Front Immunol; 2021; 12():633796. PubMed ID: 33841415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of FAK/Rac1/Cdc42-GTPase signaling ameliorates impaired microglial migration response to Aβ
    Rong Z; Cheng B; Zhong L; Ye X; Li X; Jia L; Li Y; Shue F; Wang N; Cheng Y; Huang X; Liu CC; Fryer JD; Wang X; Zhang YW; Zheng H
    FASEB J; 2020 Aug; 34(8):10984-10997. PubMed ID: 32613609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
    Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
    J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.